this is even more true in developing areas, where the availability of safe and low cost products might improve greatly agriculture, zootechnics, health, trade, and economics. Genetic engineering and biotechnology are making available new knowledge and tools in vaccine technology, allowing molecular
β¦ LIBER β¦
What's new: Hybridoma technology in immunocytochemistry
β Scribed by A. Claudio Cuello; Cesar Milstein
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 298 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0265-9247
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
What's going on in vaccine technology?
β
Silvia Russo; Lauretta Turin; Antonio Zanella; Wilma Ponti; Giorgio Poli
π
Article
π
1997
π
John Wiley and Sons
π
English
β 223 KB
What' New: More advances in DNA sequenci
β
Deborah Wilde
π
Article
π
1985
π
John Wiley and Sons
π
English
β 364 KB
Screening for weak monoclonal antibodies
β
Lisa Leickt; Anders Grubb; Sten Ohlson
π
Article
π
1998
π
John Wiley and Sons
π
English
β 46 KB
π 2 views
As the interest in weak-affinity antibodies has been widened by their introduction to various analytical techniques such as HPLC, capillary electrophoresis and biosensors, there has been a need for new screening/ monitoring methods. In this study, weak-affinity chromatography was adopted to screen/m
What's new in JASIST
β
Donald H. Kraft
π
Article
π
2002
π
John Wiley and Sons
π
English
β 31 KB
Whatβ²s New in Chirality
β
Laurent Pinchard
π
Article
π
2005
π
John Wiley and Sons
β 8 KB
## Abstract For Abstract see ChemInform Abstract in Full Text.
ChemInform Abstract: Whatβ²s Going on in
β
S. RUSSO; L. TURIN; A. ZANELLA; W. PONTI; G. POLI
π
Article
π
2010
π
John Wiley and Sons
β 24 KB